Zobrazeno 1 - 10
of 121
pro vyhledávání: '"I. Díaz-Maroto"'
Autor:
I. Díaz-Maroto, J. García-García, P.A. Sánchez-Ayaso, C. Alcahut-Rodríguez, E. González-Villar, J.M. Pardal-Fernández, T. Segura
Publikováno v:
Neurología (English Edition), Vol 38, Iss 4, Pp 229-235 (2023)
Introduction: Ocular myasthenia gravis (MG) is the most common phenotype of MG at onset. A variable percentage of these patients develop secondary generalisation; the risk factors for conversion and the protective effect of immunosuppressive treatmen
Externí odkaz:
https://doaj.org/article/58afa0d6b1f84784a75ccc5a88800310
Publikováno v:
Neurología (English Edition), Vol 38, Iss 4, Pp 256-261 (2023)
Introduction: Advances in the treatment of myasthenia gravis (MG) have improved quality of life and prognosis for the majority of patients. However, 10%–20% of patients present refractory MG, with frequent relapses and significant functional limita
Externí odkaz:
https://doaj.org/article/75688cf7c1144cf4990bdb1990d11dce
Autor:
Á. Martínez-Martín, J. García-García, I. Díaz-Maroto Cicuéndez, M.L. Quintanilla-Mata, T. Segura
Publikováno v:
Neurología, Vol 37, Iss 8, Pp 709-710 (2022)
Externí odkaz:
https://doaj.org/article/d01aa6e3bddf4dc687c11ecf36c64f47
Autor:
Á. Martínez-Martín, J. García-García, I. Díaz-Maroto Cicuéndez, M.L. Quintanilla-Mata, T. Segura
Publikováno v:
Neurología (English Edition), Vol 37, Iss 8, Pp 709-710 (2022)
Externí odkaz:
https://doaj.org/article/cdcab18229c7404fb41eb9e18fc57e2c
Publikováno v:
Neurología (English Edition), Vol 36, Iss 3, Pp 243-245 (2021)
Externí odkaz:
https://doaj.org/article/c2aa9c7730e641a3a6d629547d494f54
Publikováno v:
Neurología, Vol 36, Iss 3, Pp 243-245 (2021)
Externí odkaz:
https://doaj.org/article/d47bf7b9d858441c96ad25d594098c1f
Publikováno v:
Neurología (English Edition), Vol 35, Iss 7, Pp 510-512 (2020)
Externí odkaz:
https://doaj.org/article/9cecc277052e47fca4002111fd81ee11
Publikováno v:
Neurología, Vol 35, Iss 7, Pp 510-512 (2020)
Externí odkaz:
https://doaj.org/article/6990e35a4000466e84d06f3172560778
Publikováno v:
Neurología. 38:256-261
INTRODUCTION Advances in the treatment of myasthenia gravis (MG) have improved quality of life and prognosis for the majority of patients. However, 10%-20% of patients present refractory MG, with frequent relapses and significant functional limitatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05fb1c421efa7ba8e4e993866a097657
https://doi.org/10.1016/j.nrl.2020.08.016
https://doi.org/10.1016/j.nrl.2020.08.016
Autor:
Jorge García-García, E. González-Villar, I. Díaz-Maroto, P.A. Sánchez-Ayaso, J.M. Pardal-Fernández, Tomás Segura, C. Alcahut-Rodríguez
Publikováno v:
Neurología. 38:229-235
Resumen Introduccion La miastenia gravis ocular (MGo) es la forma de presentacion de la enfermedad mas frecuente. Un porcentaje variable de estos pacientes desarrollan una forma generalizada (MGg), siendo los factores de riesgo de conversion y el efe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6c78d901b5858d0015aed1118ec8612
https://doi.org/10.1016/j.nrl.2020.09.004
https://doi.org/10.1016/j.nrl.2020.09.004